Scarica l'app Stockscreener
1.59
0.63%
0.01
Dopo l'orario di chiusura:
1.48
-0.11
-6.92%
Silexion Therapeutics Corp Borsa (SLXN) Ultime notizie
Breakouts Watch: Can Silexion Therapeutics Corp sustain its profitability2025 Key Lessons & Daily Stock Momentum Reports - baoquankhu1.vn
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - mfd.ru
Momentum Shift: Should I hold or sell Silexion Therapeutics Corp now2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Can Silexion Therapeutics Corp sustain its profitability2025 Big Picture & Proven Capital Preservation Methods - mfd.ru
What’s the beta of Silexion Therapeutics Corp Equity Warrant stockJuly 2025 Highlights & Daily Risk Controlled Trade Plans - mfd.ru
Is Silexion Therapeutics Corp stock affected by interest rate hikesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru
What’s the profit margin of Silexion Therapeutics CorpAnalyst Upgrade & Safe Entry Trade Reports - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant stock deliver strong Q4 earningsJuly 2025 Setups & Weekly High Potential Alerts - mfd.ru
Trading Recap: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Analyst Downgrade: Can Silexion Therapeutics Corp be recession proofMarket Trend Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress - TipRanks
Silexion Therapeutics Corp Prepares Investor Presentation on SIL204 - TradingView
Jobs Data: What is ALBTs P E ratio telling us2025 Sector Review & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Opening: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Profit Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Gap Down: Can Silexion Therapeutics Corp be recession proofQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Risk Hedge: Can Spring Valley Acquisition Corp II Equity Warrant sustain its profitability2025 Biggest Moves & Reliable Entry Point Alerts - baoquankhu1.vn
Investment Review: Can Silexion Therapeutics Corp Equity Warrant expand its profit marginsQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Silexion shares skyrocket 400% after encouraging pancreatic cancer drug results - MSN
Growth Value: What is the implied volatility of Silexion Therapeutics Corp2025 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit - manilatimes.net
Silexion Therapeutics to Participate in 7th RNAi-Based Therapeutics Summit Focused on Advancing SIL204 for Pancreatic Cancer - Quiver Quantitative
Will Silexion Therapeutics Corp benefit from geopolitical trendsSector ETF Performance & Free Double Digit Growth Tips - bollywoodhelpline.com
Retail Surge: Whats the RSI of Kirby Corporation stock2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Silexion reports breakthrough in KRAS cancer therapy - MSN
Signal Recap: What is the PEG ratio of Silexion Therapeutics Corp Equity Warrant2025 Key Lessons & Detailed Earnings Play Strategies - baoquankhu1.vn
Is Silexion Therapeutics Corp a defensive stockAnalyst Upgrade & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Silexion stock jumps after toxicology studies show no systemic toxicity - MSN
Can Silexion Therapeutics Corp Equity Warrant stock sustain free cash flow growthJuly 2025 Opening Moves & Fast Gain Swing Alerts - ulpravda.ru
Why Silexion Therapeutics Corp Equity Warrant stock attracts high net worth investorsFit and Size Notes & quick comparison of popular models - Улправда
Can Silexion Therapeutics Corp Equity Warrant stock beat market expectations this quarterRecession Risk & Fast Exit Strategy with Risk Control - Улправда
Dividend Watch: Will Silexion Therapeutics Corp stock deliver strong dividend growthPortfolio Risk Summary & Fast Moving Market Watchlists - Улправда
Is Silexion Therapeutics Corp stock a buy for dividend growthJuly 2025 Final Week & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why retail investors favor Silexion Therapeutics Corp stockQuarterly Market Review & Free High Accuracy Swing Entry Alerts - ulpravda.ru
How strong is Silexion Therapeutics Corp stock revenue growthProduct Launch & Entry Point Confirmation Signals - Улправда
Will Silexion Therapeutics Corp stock deliver strong dividend growthPortfolio Risk Summary & Fast Moving Market Watchlists - Улправда
What momentum indicators show for Silexion Therapeutics Corp Equity Warrant stockMarket Performance Recap & Free Long-Term Investment Growth Plans - ulpravda.ru
Will Silexion Therapeutics Corp Equity Warrant stock reach Wall Street targetsJuly 2025 Spike Watch & Daily Entry Point Trade Alerts - Улправда
Can Silexion Therapeutics Corp stock weather global recession2025 Price Action Summary & Short-Term High Return Strategies - Улправда
Signal Recap: What technical signals suggest for Silexion Therapeutics Corp stockWeekly Market Report & Consistent Growth Equity Picks - ulpravda.ru
Will Silexion Therapeutics Corp stock outperform Dow Jones indexTrade Entry Summary & Community Driven Trade Alerts - ulpravda.ru
Silexion Therapeutics CorpOrdinary Shares (NQ: SLXN - FinancialContent
Silexion outlines 2026 plans after transformational 2025 progress - TipRanks
Silexion Therapeutics Corp Highlights 2025 Achievements and 2026 Milestones - TradingView — Track All Markets
Silexion Therapeutics' Cancer Drug to Enter Human Trials in Early 2026 - marketscreener.com
Silexion Therapeutics Reports Promising Preclinical Results for SIL204 in KRAS-Driven Cancers and Plans Phase 2/3 Trial Initiation for 2026 - Quiver Quantitative
Silexion Therapeutics Releases CEO Letter to Shareholders - GlobeNewswire
Cash per share of Silexion Therapeutics Corp Warrant – NASDAQ:SLXNW - TradingView — Track All Markets
Merger Talk: Is Silexion Therapeutics Corp Equity Warrant stock trading at a premium valuation2025 Top Decliners & Daily Volume Surge Signals - Bộ Nội Vụ
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Risk Hedge: Will Silexion Therapeutics Corp stock deliver strong dividend growth2025 Market Overview & Safe Capital Growth Stock Tips - Bộ Nội Vụ
Can Silexion Therapeutics Corp Equity Warrant stock hit analyst price targetsJuly 2025 Retail & Free Technical Pattern Based Buy Signals - Улправда
Can Silexion Therapeutics Corp Equity Warrant stock hit record highs againJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - Улправда
Will Silexion Therapeutics Corp Equity Warrant stock pay special dividendsTrade Exit Report & Weekly Top Performers Watchlists - DonanımHaber
How Silexion Therapeutics Corp stock compares to growth peersQuarterly Performance Summary & Free Real-Time Market Sentiment Alerts - DonanımHaber
Risk Analysis: Can Silexion Therapeutics Corp Equity Warrant stock hit analyst price targetsPortfolio Risk Report & High Conviction Trade Alerts - Улправда
Treasury Yields: How strong is Silexion Therapeutics Corp stock revenue growthWeekly Trade Report & AI Based Buy and Sell Signals - DonanımHaber
Silexion Therapeutics (NASDAQ:SLXN) Upgraded at Zacks Research - Defense World
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):